Most bariatric procedures work primarily by restriction -- making the stomach smaller so you eat less. The gastric bypass adds mild malabsorption. The duodenal switch goes further. It combines a sleeve gastrectomy with a significant rerouting of the small intestine, bypassing 60-75% of its absorptive length. The result is the most weight loss, the most metabolic improvement, and the most demanding nutritional follow-up of any bariatric procedure in current practice.
The DS exists because some patients need more than restriction. A BMI of 55 or 60 isn't the same clinical problem as a BMI of 40, and the procedures that work well for BMI 40 sometimes aren't enough for the patient who starts at 60. The DS is the tool that was built for this population.
How the procedure works
The two-component design
The duodenal switch is actually two procedures in one operation:
Component 1: Sleeve gastrectomy. Roughly 75-80% of the stomach is removed, leaving a tubular pouch -- the same sleeve created in a standalone sleeve gastrectomy. This provides the restriction.
Component 2: Intestinal rerouting. The duodenum (the first section of the small intestine, just below the stomach) is divided, and the lower portion of the small intestine (the ileum) is connected directly to the duodenum. The bypassed portion of the intestine -- carrying bile and digestive enzymes -- reconnects further downstream, so food and digestive juices only mix in the final 75-150 cm of intestine. This provides the malabsorption.
BPD/DS vs SADI-S
The traditional BPD/DS (biliopancreatic diversion with duodenal switch) creates two intestinal connections. The newer SADI-S (single anastomosis duodeno-ileal bypass with sleeve gastrectomy) achieves a similar result with a single connection, analogous to how the mini bypass simplifies the Roux-en-Y. Both are offered in Colombia; the SADI-S is gaining favour because of its simpler construction while maintaining comparable weight loss.
The staged approach
For patients with a very high BMI (60+), some surgeons perform the DS in two stages: a sleeve gastrectomy first, followed by the intestinal rerouting 6-12 months later after the patient has lost initial weight and reduced surgical risk. This is a well-established approach -- not a sign of inadequacy, but a risk-management strategy. Ask your surgeon whether a staged approach is appropriate for your BMI and comorbidity profile.
Who the duodenal switch is for
Primary candidates
- BMI 50+ (super-obese). This is the procedure's primary population. At BMIs above 50, the sleeve alone typically produces insufficient weight loss, and the standard bypass may not create enough malabsorption. The DS is the most reliable route to meaningful, sustained weight loss in this range.
- BMI 40+ with severe type 2 diabetes. The DS has the highest diabetes remission rate of any bariatric procedure -- published data shows remission rates exceeding 90% in some series. For patients whose diabetes is the primary driver, the DS's metabolic impact is its strongest argument.
- Patients who've had insufficient weight loss from a prior sleeve. The DS can be performed as a revision -- adding the intestinal component to an existing sleeve. This is a common indication and one where the DS's design is uniquely suited.
Who should consider other procedures instead
- BMI 35-45 without severe metabolic disease. The sleeve or bypass produces excellent results in this range with substantially lower nutritional risk. Using the DS for a patient who would do well with a sleeve is not a favour -- it's unnecessary malabsorption.
- Patients unable to commit to lifelong supplementation and monitoring. This is not a lifestyle preference -- it's a medical requirement. Protein malnutrition, fat-soluble vitamin deficiency, and calcium malabsorption are predictable consequences of the DS anatomy, and they're preventable only with consistent supplementation and regular lab monitoring.
- Patients with existing malabsorptive conditions (Crohn's disease, short bowel syndrome, celiac disease). The DS adds malabsorption to a system that may already have too little absorptive capacity.
The nutritional reality
Every bariatric procedure requires lifelong supplements. The DS requires more, taken more seriously, with higher consequences for skipping.
| Supplement | Daily dose | Why it matters |
|---|---|---|
| Bariatric multivitamin | 2x daily (not 1) | Baseline coverage for all micronutrients. Must be bariatric-formulated -- standard multivitamins are insufficient. |
| Calcium citrate + vitamin D3 | 1,800-2,400 mg Ca / 3,000-6,000 IU D3 | The DS drastically reduces calcium absorption. Bone density loss is the most common long-term complication when supplementation is inadequate. |
| Vitamin B12 | 1,000 mcg sublingual or monthly injection | B12 absorption drops significantly. Deficiency causes neurological symptoms that can be irreversible. |
| Iron | 45-60 mg elemental | Iron absorption is reduced by the bypassed duodenum. Anaemia is common without supplementation. |
| Fat-soluble vitamins (A, E, K) | Per labs | Fat malabsorption reduces absorption of all fat-soluble vitamins. Dose guided by quarterly labs in year one, annual labs thereafter. |
| Protein | 80-120g daily | Protein malabsorption is significant. Most DS patients need protein supplements to hit targets. Protein malnutrition is the complication that sends DS patients back to hospital. |
The non-negotiable commitment
This supplement schedule is not optional, not temporary, and not something you can decide to stop once you've reached your goal weight. The DS anatomy permanently reduces your absorptive capacity. Stopping supplements after the DS leads to predictable, preventable deficiencies that cause bone loss, anaemia, neurological damage, and protein malnutrition. Your programme should monitor labs quarterly in year one and annually forever. If they don't, you need a different programme.
The duodenal switch in Colombia
Availability and surgeon verification
Fewer Colombian bariatric surgeons offer the duodenal switch compared to the sleeve or bypass. The procedure's complexity means you need a surgeon with specific DS experience, not just general bariatric experience. When evaluating a Colombian programme for the DS, ask the following:
- How many DS procedures has the surgeon performed as primary surgeon? (Minimum: 30-50 for a surgeon you'd trust with this operation.)
- Does the surgeon offer both BPD/DS and SADI-S, and which does the surgeon recommend for your case?
- Is the procedure performed in a hospital with full ICU capability? (This is non-negotiable for the DS.)
- What is the surgeon's reported complication rate for DS specifically?
- Does the programme have a structured long-term nutritional follow-up protocol for DS patients?
Standard verification applies: ReTHUS registration, IFSO or ASMBS membership, and hospital privileges at a JCI-accredited or ICONTEC-accredited facility. For the full walkthrough, see the surgeon verification checklist.
The cost picture
A duodenal switch at an accredited Colombian hospital typically costs $10,000 to $15,000 for the surgical package. This is the most expensive bariatric procedure in Colombia, reflecting 3-5 hours of operating time, greater surgical complexity, and a longer hospital stay (typically 3-5 nights). The US self-pay cost ranges from $25,000 to $40,000 or more, and insurance coverage for the DS is inconsistent.
The all-in first-year cost in Colombia -- including flights, accommodation for a longer recovery stay (14-21 days recommended), companion, workup, and supplements -- runs approximately $16,000 to $22,000. That's still substantially less than the US procedure-only cost, but it's important to budget accurately for the longer in-country stay.
Outcomes and honest expectations
The DS produces the most weight loss: 70-85% of excess body weight at five years, which is substantially better than the sleeve (50-60%) and modestly better than the bypass (55-70%) at the same time point. For patients starting at a BMI of 55+, this difference is clinically meaningful -- the DS brings more patients into a non-obese BMI range than any other single procedure.
Diabetes remission rates exceed 90% in published DS series, outperforming both the sleeve and the bypass. For patients whose diabetes is poorly controlled despite medication, the DS's metabolic impact may be the strongest clinical argument for choosing it.
The trade-off is clear: more weight loss and better metabolic outcomes, in exchange for a more complex operation, a longer recovery, and a lifelong nutritional commitment that is substantially more demanding than any other bariatric procedure.
The duodenal switch is not a bigger version of the sleeve. It is a different category of operation with different outcomes, different risks, and different demands on the patient who lives with the result. Choose it because the math supports it for your case, not because "more" sounds better.
For the broader picture of bariatric options in Colombia, start with the sleeve vs bypass decision framework and the comprehensive bariatric guide. For the full network of Colombian medical specialties, ColombiaMedical.co is the hub.
Is the duodenal switch right for your case?
The DS is a major decision. Send us your BMI, metabolic profile, and surgical history. We'll connect you with Colombian programmes that offer the DS and help you understand whether it's the right level of intervention for your situation.
Get a written quote WhatsApp us